← Browse by Condition
Medical Condition
epithelioid sarcoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2, Phase 2
NCT04390737 Phase 1, Phase 2
Recruiting
Evaluate the Safety and Clinical Activity of HH2853
Enrollment
254 pts
Location
United States, China
Sponsor
Haihe Biopharma Co., Ltd.
NCT06277154 Phase 2
Recruiting
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
Enrollment
148 pts
Location
China
Sponsor
HRYZ Biotech Co.